Assessing seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city of India: a cross-sectional study

Nav

General Info

Geography

India (IND)

Gujarat

Time period covered

01/2020 - 12/2020

Data type

Scientific literature

Keywords

Blood tests, COVID-19, Disease outbreaks

Citation

Authors

Prakash O, Solanki B, Sheth JK, Joshi B, Kadam M, Vyas S, Shukla A, Tiwari H, Rathod S, Rajput A, Trivedi T, Ramanuj V, Solanki A

Journal

BMJ Open

Volume

Issue

Pages

e044101

Publication year

2021

Suggested citation

Prakash O, Solanki B, Sheth JK, Joshi B, Kadam M, Vyas S, Shukla A, Tiwari H, Rathod S, Rajput A, Trivedi T, Ramanuj V, Solanki A. Assessing seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city of India: a cross-sectional study. BMJ Open. 2021; 11(1): e044101.

DOI

10.1136/bmjopen-2020-044101

PMID

33402413

GHDx Entry last modified on: Jan 31, 2024

Header sites

Search form

Main menu

Assessing seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city of India: a cross-sectional study

Nav